Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M De Santis

Showing results (271-280 of 305) with videos related to

Pageof 31
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 21, 2025
Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III studyK Fizazi, N W Clarke, M De Santis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2025
Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trialT Powles, S Tagawa, C Vulsteke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2014
Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancerJ Oldenburg, J Aparicio, J Beyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2011
2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trialM Bachner, Y Loriot, M Gross-Goupil, et al.
European Journal of Internal Medicine|April 10, 2024
Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature reviewA Dima, M C Vonk, A Garaiman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 5, 2015
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015S Gillessen, A Omlin, G Attard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2016
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015S Gillessen, A Omlin, G Attard, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 15, 2003
The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic riskF Podo, F Sardanelli, R Canese, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 16, 2012
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancerJ Beyer, P Albers, R Altena, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2019
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†A Horwich, M Babjuk, J Bellmunt, et al.
Pageof 31

Showing results (271-280 of 305) with videos related to

Sort By:
Pageof 31
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 21, 2025
Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III studyK Fizazi, N W Clarke, M De Santis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2025
Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trialT Powles, S Tagawa, C Vulsteke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2014
Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancerJ Oldenburg, J Aparicio, J Beyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2011
2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trialM Bachner, Y Loriot, M Gross-Goupil, et al.
European Journal of Internal Medicine|April 10, 2024
Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature reviewA Dima, M C Vonk, A Garaiman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 5, 2015
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015S Gillessen, A Omlin, G Attard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2016
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015S Gillessen, A Omlin, G Attard, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 15, 2003
The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic riskF Podo, F Sardanelli, R Canese, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 16, 2012
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancerJ Beyer, P Albers, R Altena, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2019
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†A Horwich, M Babjuk, J Bellmunt, et al.
Pageof 31